Published in J Vasc Surg on April 14, 2011
ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. Ann Thorac Surg (2012) 2.18
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Role of prostacyclin in the cardiovascular response to thromboxane A2. Science (2002) 4.59
Mechanisms of stenosis after arterial injury. Lab Invest (1983) 3.75
Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol (2007) 3.62
Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 2.59
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem (2001) 2.40
Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow. Blood (2010) 2.23
Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell (2008) 2.21
ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell (2009) 2.20
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res (2006) 1.83
A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res (2002) 1.72
Identification and characterization of a prostaglandin transporter. Science (1995) 1.65
Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med (2000) 1.60
The functions of plasminogen in cardiovascular disease. Trends Cardiovasc Med (2004) 1.31
The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol (2004) 1.31
Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J Biol Chem (2000) 1.30
Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol (1997) 1.28
Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. Am J Pathol (2009) 1.27
TC-1 is a novel tumorigenic and natively disordered protein associated with thyroid cancer. Cancer Res (2004) 1.27
Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. Arterioscler Thromb Vasc Biol (2003) 1.25
Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation (1998) 1.25
Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage. Osteoarthritis Cartilage (2005) 1.24
Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn (2007) 1.24
FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. Cardiovasc Res (2004) 1.24
Versican degradation and vascular disease. Trends Cardiovasc Med (2006) 1.23
Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest (1996) 1.23
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol (2004) 1.17
Review: Trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta (2010) 1.17
A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res (2002) 1.14
TC1 (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby. Cancer Res (2006) 1.13
Pericellular plasmin induces smooth muscle cell anoikis. FASEB J (2003) 1.12
Cloning of TC-1 (C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics (2000) 1.10
Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids. Arterioscler Thromb Vasc Biol (1998) 1.09
A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. J Clin Invest (2003) 1.09
Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol (2008) 1.06
The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum (2007) 1.05
Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol (1998) 1.01
Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg (2002) 1.00
The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage (2006) 0.99
PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. FASEB J (2003) 0.98
Prostanoid receptors in the human vascular wall. ScientificWorldJournal (2007) 0.97
Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res (1998) 0.96
Histopathologic analysis of in-stent neointimal regression in a porcine coronary model. Coron Artery Dis (2000) 0.95
Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genomics (2010) 0.95
Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. J Vasc Surg (2003) 0.95
Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol (2002) 0.94
Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice. Circulation (2010) 0.94
Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy. J Vasc Surg (2006) 0.93
Induction of vascular atrophy as a novel approach to treating restenosis. A review. J Vasc Surg (2007) 0.92
TC1(C8orf4) is upregulated by IL-1beta/TNF-alpha and enhances proliferation of human follicular dendritic cells. FEBS Lett (2006) 0.92
Silencing of Mustn1 inhibits myogenic fusion and differentiation. Am J Physiol Cell Physiol (2010) 0.92
Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem (2005) 0.90
Loss of cell viability dramatically elevates cell surface plasminogen binding and activation. Exp Cell Res (1998) 0.90
Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ (2002) 0.89
Mustn1 is expressed during chondrogenesis and is necessary for chondrocyte proliferation and differentiation in vitro. Bone (2009) 0.89
Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice. Circulation (2010) 0.88
Cell death-associated ADAMTS4 and versican degradation in vascular tissue. J Histochem Cytochem (2009) 0.87
Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation (2006) 0.87
Matrilin-3 activates the expression of osteoarthritis-associated genes in primary human chondrocytes. FEBS Lett (2009) 0.87
Shear stress induces apoptosis in vascular smooth muscle cells via an autocrine Fas/FasL pathway. Biochem Biophys Res Commun (2003) 0.85
Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol (1999) 0.85
Caspases from apoptotic myocytes degrade extracellular matrix: a novel remodeling paradigm. FASEB J (2005) 0.83
Intimal hyperplasia regression from 6 to 12 months after stenting. Am J Cardiol (2002) 0.82
Autologous apoptotic cell engulfment stimulates chemokine secretion by vascular smooth muscle cells. Am J Pathol (2005) 0.80
Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury. J Vasc Res (2004) 0.79
Increased ecto-metallopeptidase activity in cells undergoing apoptosis. J Cell Biochem (2000) 0.78
Effects of external wrapping and increased blood flow on atrophy of the baboon iliac artery. J Vasc Surg (2008) 0.77
Modulation of hyaluronan fragmentation by interleukin-1 beta in synovial membrane cells. Ann Biomed Eng (2010) 0.76
Removal of O-linked and N-linked oligosaccharides is required for optimum detection of NITEGE neoepitope on ADAMTS4-digested fetal aggrecans: implications for specific N-linked glycan-dependent aggrecanolysis at Glu373-Ala374. Osteoarthritis Cartilage (2008) 0.76
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg (2006) 3.38
Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Current strategy for the treatment of symptomatic spontaneous isolated dissection of superior mesenteric artery. J Vasc Surg (2011) 1.79
Evaluation of the efficacy of the forearm basilic vein transposition arteriovenous fistula. J Vasc Surg (2010) 1.61
Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 1.31
Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med (2006) 1.30
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg (2005) 1.26
Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res (2005) 1.24
Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res (2004) 1.23
Images in cardiovascular medicine. Serial high-spatial-resolution, multisequence magnetic resonance imaging studies identify fibrous cap rupture and penetrating ulcer into carotid atherosclerotic plaque. Circulation (2006) 1.13
Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol (2011) 1.11
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res (2003) 1.05
Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem (2005) 1.04
Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg (2003) 1.03
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients. J Vasc Surg (2003) 1.02
Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes (2011) 1.01
Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg (2002) 1.00
Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg (2005) 0.98
Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg (2007) 0.96
Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol (2002) 0.94
Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells. Arterioscler Thromb Vasc Biol (2002) 0.94
Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy. J Vasc Surg (2006) 0.93
Twentieth anniversary of American Vascular Association/Lifeline Foundation: a celebration. J Vasc Surg (2008) 0.93
Synectin-dependent gene expression in endothelial cells. Physiol Genomics (2006) 0.92
Induction of vascular atrophy as a novel approach to treating restenosis. A review. J Vasc Surg (2007) 0.92
VASP increases hepatic fatty acid oxidation by activating AMPK in mice. Diabetes (2013) 0.92
Concomitant blockade of platelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts. J Vasc Surg (2004) 0.91
High prevalence of peripheral arterial disease in Korean patients with coronary or cerebrovascular disease. J Korean Med Sci (2012) 0.91
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg (2006) 0.90
Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem (2005) 0.90
Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. J Vasc Surg (2004) 0.90
Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion. J Vasc Surg (2011) 0.89
MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9. Cardiovasc Res (2004) 0.88
Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. J Vasc Surg (2009) 0.88
Reconstruction of portal vein and superior mesenteric vein after extensive resection for pancreatic cancer. J Korean Surg Soc (2013) 0.87
Cell death-associated ADAMTS4 and versican degradation in vascular tissue. J Histochem Cytochem (2009) 0.87
Vasospasm as a cause for claudication in athletes with external iliac artery endofibrosis. J Vasc Surg (2013) 0.86
Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients. Nephrol Dial Transplant (2013) 0.85
The outcomes of percutaneous versus open placement of peritoneal dialysis catheters. World J Surg (2014) 0.84
Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia. Arterioscler Thromb Vasc Biol (2009) 0.84
Trends in deceased organ donation and utilization in Korea: 2000-2009. J Korean Med Sci (2010) 0.83
VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen. J Cell Physiol (2010) 0.82
Sequential evolution of IL-17 responses in the early period of allograft rejection. Exp Mol Med (2009) 0.82
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. Transplantation (2010) 0.81
Early sustained injections of erythropoietin improve angiogenesis and restoration of perfusion in the ischemic mouse hindlimb. J Korean Med Sci (2012) 0.81
Interleukin-1beta inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells. J Vasc Surg (2004) 0.80
Successful thrombolysis, angioplasty, and stenting of delayed thrombosis in the vena cava following percutaneous vertebroplasty with polymethylmethacrylate cement. J Vasc Surg (2012) 0.80
Tissue responses to endovascular stent grafts for saccular abdominal aortic aneurysms in a canine model. J Korean Med Sci (2012) 0.79
Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation. J Korean Surg Soc (2012) 0.79
CT venography for deep venous thrombosis: can it predict catheter-directed thrombolysis prognosis in patients with iliac vein compression syndrome? Int J Cardiovasc Imaging (2014) 0.79
Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases. Arterioscler Thromb Vasc Biol (2004) 0.79
Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement. Int J Cardiovasc Intervent (2003) 0.78
Low levels of a natural IgM antibody are associated with vein graft stenosis and failure. J Vasc Surg (2013) 0.78
Successful percutaneous thrombectomy of an infected vena-caval thrombus due to a toothpick. J Vasc Surg (2011) 0.78
Dacron patch infection after carotid endarterectomy: case report and review of the literature. Ann Vasc Surg (2006) 0.78
Effects of external wrapping and increased blood flow on atrophy of the baboon iliac artery. J Vasc Surg (2008) 0.77
The toxicity and distribution of iron oxide-zinc oxide core-shell nanoparticles in C57BL/6 mice after repeated subcutaneous administration. J Appl Toxicol (2015) 0.77
Comparison of costs of endovascular repair versus open surgical repair for abdominal aortic aneurysm in Korea. J Korean Med Sci (2012) 0.77
Arterial injury repair in nonhuman primates-the role of PDGF receptor-beta. J Surg Res (2004) 0.77
Comparative toxicity of silicon dioxide, silver and iron oxide nanoparticles after repeated oral administration to rats. J Appl Toxicol (2015) 0.77
Efficient gene transfer and durable transgene expression in grafted rabbit veins. Hum Gene Ther (2015) 0.76
Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, Topors. PLoS One (2012) 0.75
Major vascular injury during nonvascular surgeries. Ann Vasc Surg (2012) 0.75
Different Recurrence Rates Between Pediatric and Adult Renal Transplant for Immunoglobulin A Nephropathy: Predictors of Posttransplant Recurrence. Exp Clin Transplant (2015) 0.75
Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients. Am J Nephrol (2016) 0.75